SCHEMBL5261017

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL5259179	0.82	SRC (0.57)	SRCMEN1KMT2AGSK3BLMNA
	SCHEMBL5256981	0.80	SRC (0.52)	SRCMEN1KMT2AGSK3BLMNA
	SCHEMBL5257571	0.76	SRC (0.54)	SRCMEN1KMT2ALMNAHTT
	SCHEMBL5261442	0.76	SRC (0.64)	SRCMEN1KMT2ALMNAHTT
	SCHEMBL5258012	0.75	SRC (0.50)	SRCMEN1KMT2ALMNAHTT
	SCHEMBL5257423	0.74	SRC (0.46)	SRCMEN1KMT2ALMNAHTT
	SCHEMBL5259379	0.74	SRC (0.49)	SRCMEN1KMT2AGSK3BLMNA
	SCHEMBL5257567	0.71	SRC (0.49)	SRCMEN1KMT2ALMNAHTT
	SCHEMBL5259370	0.69	SRC (0.56)	SRCMEN1KMT2ALMNAHTT
	SCHEMBL5261087	0.69	SRC (0.50)	SRCMEN1KMT2AGSK3BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.